| Detected | Trial | Change |
|---|---|---|
| 2026-08-09 | NCT06443307 Real-world Study to Evaluate the Efficacy and Safety of Liposome Irinotecan |
overall status: Recruiting → Unknown |
| 2026-08-09 | NCT05933668 Mutant KRAS G12V-specific TCR Transduced T Cell Therapy for Advanced Solid Tumor |
overall status: Not Yet Recruiting → Unknown |
| 2026-08-06 | NCT07127822 Assessing Iparomlimab and Tuvonralimab in Recurrent or Metastatic MSI-H/dMMR Gastric… |
Recruitment opened |
| 2026-08-06 | NCT07127822 Assessing Iparomlimab and Tuvonralimab in Recurrent or Metastatic MSI-H/dMMR Gastric… |
Trial sites expanded: 1 -> 10 locations |
| 2026-07-29 | NCT06199232 Targeted Treatment Plus Tislelizumab and HAIC for Advanced CRCLM Failed From Standard… |
Trial completed |
| 2026-07-29 | NCT06199232 Targeted Treatment Plus Tislelizumab and HAIC for Advanced CRCLM Failed From Standard… |
date change Completion moved earlier: 2027-06-23 -> 2026-07-10 |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-07-29 | NCT07735091 A Blood Pressure-Lowering Diet for Preventing and Managing Hypertension | Not Yet Recruiting | |
| 2026-07-24 | NCT07726615 Time-Restricted Eating and Staple Food Reduction Combined With App-Supported Exercise for… | Not Yet Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT06963593 | Clinical Study on the Treatment of Anorexia and Cachexia in Advanced Gastric and… | Advanced Gastroesophageal Cancer | Not Yet Recruiting |
| NCT07646886 | Botulinum Toxin Type A Injection Sites for Oral Commissure Ptosis | Facial Aging | Not Yet Recruiting |
| Phase 3 | |||
| NCT02535221 | Neoadjuvant Endocrine Therapy Versus Chemotherapy in Premenopausal Patients With ER+ &… | Breast Cancer | Recruiting |
| NCT07677293 | Retlirafusp Alfa Injection Plus Chemotherapy Versus Investigator's Choice of Anti-PD-1… | Gastric Adenocarcinoma and Gastroesophageal Junction Adenocarcinoma | Not Yet Recruiting |
| Phase 2 | |||
| NCT04481932 | Trastuzumab Combined With Pyrrolidine and Chemotherapy for Locally HER2 Positive Breast… | HER2-positive Breast Cancer | Recruiting |
| NCT06347653 | Linperlisib-based Treatment Regimen in Newly Diagnosed Nodal T-follicular Helper Cell… | Nodal T-follicular Helper Cell Lymphoma | Recruiting |
| NCT06023758 | Phase 2 Trial of KN026+KN046±XELOX in HER2-positive Locally Advanced GC | HER2-positive Locally Advanced Resectable Gastric Cancer | Recruiting |
| NCT06684600 | Study of Dalpiciclib Isethionate Plus Pyrotinib Maleate in the Treatment of Advanced… | Esophageal Squamous Cell Carcinoma | Recruiting |
| NCT05165407 | Sintilimab Combined With IBI310 and Surufatinib for the Treatment of G3-NET and NEC… | Neuroendocrine Neoplasm | Recruiting |
| NCT06580574 | Immune Checkpoint Inhibitors for Organ Preservation in Non-metastatic dMMR/MSI-H Gastric… | Gastric Cancer | Recruiting |
| NCT07127822 | Assessing Iparomlimab and Tuvonralimab in Recurrent or Metastatic MSI-H/dMMR Gastric… | Gastric / Gastroesophageal Junction Adenocarcinoma | Recruiting |
| NCT06222944 | Anlotinib, TQB2450 (PD-L1 Inhibitor), and Albumin-bound Paclitaxel Regimens in the… | Gastric Cancer | Not Yet Recruiting |
| NCT06745193 | A Prospective, Randomized, Open, Phase II Clinical Study of Chidamide in Combination with… | Advanced Esophageal Carcinoma | Not Yet Recruiting |
| NCT05894889 | Pembrolizumab and Chemotherapy Neoadjuvant/Adjuvant of NSCLC | Stage IIIB(N2) Non-small Cell Lung Cancer | Active, Not Recruiting |
| NCT06772233 | A Study of Regorafenib Combined With Envafolimab for Metastatic Gastrointestinal Stromal… | Metastatic Gastrointestinal Stromal Tumors (GIST) | Not Yet Recruiting |
| NCT07312578 | Nimotuzumab,Camrelizumab, and Neoadjuvant Chemotherapy（nCT） in the Treatment of… | Esophageal Squamous Cell Carcinoma | Enrolling by Invitation |
| NCT04556253 | AK104 in Locally Advanced MSI-H/dMMR Gastric Carcinoma and Colorectal Cancer | MSI-H/dMMR Gastric Carcinoma and Colorectal Cancer | Active, Not Recruiting |
| NCT06650748 | Multigene Risk Score Combined With Ki-67 Dynamic Assessment in Stratified Neoadjuvant… | Breast Cancer | Enrolling by Invitation |
| Phase 1 | |||
| NCT06170294 | MAGE-A4-directed TCR-T in the Treatment Amongst Subjects With Advanced Solid Tumors | Advanced Solid Tumor | Recruiting |
| NCT06891742 | Phase I Study of OriC902 in Treatment of Advanced HCC | HCC | Recruiting |
| NCT07139067 | Phase I Clinical Study of YK1101 Injection for the Treatment of Advanced Solid Tumors | Advanced Solid Tumor Cancer | Recruiting |
| NCT06541639 | EVM16 Injection as a Single and Combination With Tislelizumab in Solid Tumors | Advanced or Recurrent Solid Tumors | Recruiting |
| NCT06134960 | NKG2D/CLDN18.21 CAR-T(KD-496) in the Treatment of Advanced NKG2DL+/CLDN18.2+ Solid Tumor | Gastric Cancer | Not Yet Recruiting |
| NCT06857786 | Postoperative Adjuvant Therapy for CT041 Gastric or Gastroesophageal Junction (G/GEJ)… | Gastroesophageal Junction Adenocarcinoma | Not Yet Recruiting |
| NCT06956261 | NW-301 TCR-T in Patients With Advanced Solid Tumor | Tumor, Solid | Not Yet Recruiting |